Methods of treating symptoms of gastroparesis using velusetrag

US11642339B2 · kind B2 · utility

Assignees

• Theravance Biopharma R&D IP, LLC · US
• ALFASIGMA S.P.A. · IT

Inventors

• Christopher Barnes · Bad Soden, DE
• Giuseppe Claudio Viscomi · Monterotondo, IT
• Cecilia RENZULLI · Bologna, IT
• Maria Grimaldi · Bologna, IT

Key dates

• Filing date: Jul 30, 2018
• Grant date: May 9, 2023
• Expiry date: Jul 30, 2038

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P1/08
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to methods and pharmaceutical compositions for treatment of all symptoms of gastroparesis in a human patient, the method comprising administering to the human patient between about 0.5 mg/day to about 30 mg/day, about 0.5 mg/day to about 15 mg/day, about 0.5 mg/day to about 5 mg/day, or about 5 mg/day, of velusetrag or a pharmaceutically-acceptable salt thereof.